Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric myelodysplastic syndromes.

Michael E Rytting1

  • 1Division of Pediatrics, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 87, Houston, TX 77030, USA. mrytting@mdanderson.org

Current Hematology Reports
|April 17, 2004
PubMed
Summary

Pediatric myelodysplastic syndromes (MDS) are clonal disorders affecting blood cell production. Current pediatric classification systems are debated, but new insights and therapies offer hope for children with MDS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coincidental Expression of Classic Hodgkin Lymphoma and Neurofibromatosis Type I and Literature Review.

Journal of pediatric hematology/oncology·2020
Same author

Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma.

Neuro-oncology·2020
Same author

Acute myeloid leukaemia.

Lancet (London, England)·2018
Same author

Phase-contrast cerebrospinal fluid flow magnetic resonance imaging in qualitative evaluation of patency of CSF flow pathways prior to infusion of chemotherapeutic and other agents into the fourth ventricle.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2017
Same author

Questions on asparaginase-associated pancreatitis.

The Lancet. Oncology·2017
Same author

Acute myeloid leukaemia masquerading as a primary CNS tumour.

BMJ case reports·2017

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) in children are clonal hematopoietic disorders.
  • These disorders lead to ineffective blood cell production, low blood counts, and an increased risk of acute myelogenous leukemia.
  • Pediatric MDS is often linked to other genetic conditions.

Purpose of the Study:

  • To review the current landscape of pediatric myelodysplastic syndromes.
  • To highlight the challenges in pediatric MDS classification compared to adult systems.
  • To discuss the potential impact of emerging biological insights and therapies on pediatric MDS treatment.

Main Methods:

  • Literature review of pediatric myelodysplastic syndromes.
  • Analysis of existing and proposed pediatric classification systems.
  • Synthesis of current research on MDS biology and novel therapeutic approaches.

Main Results:

  • Established adult MDS classification systems are not universally accepted in pediatrics.
  • Several pediatric-specific classification systems have been proposed but await widespread clinical adoption.
  • Advances in understanding MDS biology and adult treatment strategies are paving the way for pediatric advancements.

Conclusions:

  • Accurate classification remains a challenge in pediatric myelodysplastic syndromes.
  • Translating adult treatment innovations to pediatric care holds significant promise.
  • Further research and consensus on classification are needed to optimize care for children with MDS.

Related Experiment Videos